已收盘 07-10 16:00:00 美东时间
+0.090
+1.81%
Piper Sandler analyst Crispin Love maintains Arbor Realty Trust (NYSE:ABR) with a Underweight and lowers the price target from $8 to $5.5.
07-02 19:39
Arbor Realty Trust prices upsized USD 325 million convertible senior notes offering due 2029 Arbor Realty Trust priced an upsized private offering of USD 325 million 6.25% Convertible Senior Notes due 2029. Deal increased from the previously announced USD 300 million; initial purchasers hold a 13-da
07-01 09:18
阿伯房地产信托公司(ABR)宣布计划发行2029年到期的非公开发行可转换优先票据,由其子公司阿伯房地产SR公司实施,发行将遵循1933年《证券法》下144A规则...
07-01 04:13
今日重点评级关注:HC Wainwright & Co.:维持Autolus Therapeutics"买入"评级,目标价从9美元升至10美元;Maxim Group:维持Rezolute"买入"评级,目标价从4美元升至10美元
05-15 10:49
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Arbor Realty Trust shares are trading lower after the company reported worse-th...
05-09 00:09
Arbor Realty Trust Q1 net income and EPS miss analyst estimates Overview US real estate lender's Q1 net income and EPS missed analyst expectations Company's agency loan originations declined from prior quarter Company repurchased $30.7 mln of stock at 66% of book value Outlook Company did not provid
05-08 20:42
Arbor Realty Trust (NYSE:ABR) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.12 by 41.67 percent. This is a 77.42 percent decrease over earnings of $0.31 per share from
05-08 20:33
今日重点评级关注:Leerink Partners:维持Camp4 Therapeutics"跑赢大市"评级,目标价从8美元升至9美元;韦德布什:维持Arcus Biosciences"跑赢大市"评级,目标价从37美元升至41美元
04-06 16:27
Citizens analyst Chris Muller maintains Arbor Realty Trust (NYSE:ABR) with a Market Outperform and lowers the price target from $12 to $11.
04-02 23:16